Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide

Journal of Lipid Research

Volumn 51, Issue 1, 2010, Pages 74-80

  Baranowski, Marcin ^a   Blachnio Zabielska, Agnieszka ^a   Hirnle, Tomasz ^a   Harasiuk, Dorota ^a   Matlak, Krzysztof ^a   Knapp, Malgorzata ^a   Zabielski, Piotr ^a   Gorski, Jam ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Atrium; Diabetes; Heart; Human; Obesity; Papillary muscle; Sphingolipids

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; CERAMIDASE; CERAMIDE; MESSENGER RNA; PYRUVATE DEHYDROGENASE; SERINE PALMITOYLTRANSFERASE; SPHINGANINE; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE KINASE 1;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIABETIC PATIENT; DNA FRAGMENTATION; FATTY ACID METABOLISM; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART RIGHT ATRIUM; HEART VENTRICLE SEPTUM; HUMAN; LIPID BLOOD LEVEL; LIPID DEGRADATION; LIPID METABOLISM; LIPOGENESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; APOPTOSIS; BLOOD GLUCOSE; BODY MASS INDEX; CARNITINE O-PALMITOYLTRANSFERASE; CERAMIDES; DIABETES MELLITUS, TYPE 2; DNA FRAGMENTATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OBESITY; OVERWEIGHT; PROTEIN-SERINE-THREONINE KINASES; SPHINGOLIPIDS;

EID: 73149086391     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M900002-JLR200     Document Type: Article

References (35)

1. Borradaile, N. M., and J. E. Schaffer. 2005. Lipotoxicity in the heart. Curr. Hypertens. Rep. 7: 412-417.
2. Harmancey, R., C. R. Wilson, and H. Taegtmeyer. 2008. Adaptation and maladaptation of the heart in obesity. Hypertension. 52: 181-187.
3. Young, M. E., P. McNulty, and H. Taegtmeyer. 2002. Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms. Circulation. 105: 1861-1870.
4. Park, T. S., H. Yamashita, W. S. Blaner, and I. J. Goldberg. 2007. Lipids in the heart: a source of fuel and a source of toxins. Curr. Opin. Lipidol. 18: 277-282.
5. Chiu, H. C., A. Kovacs, D. A. Ford, F. F. Hsu, R. Garcia, P. Herrero, J. E. Saffitz, and J. E. Schaffer. 2001. A novel mouse model of lipotoxic cardiomyopathy. J. Clin. Invest. 107: 813-822.
6. Chiu, H. C., A. Kovacs, R. M. Blanton, X. Han, M. Courtois, C. J. Weinheimer, K. A. Yamada, S. Brunet, H. Xu, J. M. Nerbonne, et al. 2005. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ. Res. 96: 225-233.
7. Yagyu, H., G. Chen, M. Yokoyama, K. Hirata, A. Augustus, Y. Kako, T. Seo, Y. Hu, E. P. Lutz, M. Merkel, et al. 2003. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J. Clin. Invest. 111: 419-426.
8. Finck, B. N., J. J. Lehman, T. C. Leone, M. J. Welch, M. J. Bennett, A. Kovacs, X. Han, R. W. Gross, R. Kozak, G. D. Lopaschuk, et al. 2002. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109: 121-130.
9. Son, N. H., T. S. Park, H. Yamashita, M. Yokoyama, L. A. Huggins, K. Okajima, S. Homma, M. J. Szabolcs, L. S. Huang, and I. J. Goldberg. 2007. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J. Clin. Invest. 117: 2791-2801.
10. Zhou, Y. T., P. Grayburn, A. Karim, M. Shimabukuro, M. Higa, D. Baetens, L. Orci, and R. H. Unger. 2000. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. USA. 97: 1784-1789.
11. Park, T. S., Y. Hu, H. L. Noh, K. Drosatos, K. Okajima, J. Buchanan, J. Tuinei, S. Homma, X. C. Jiang, E. D. Abel, et al. 2008. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J. Lipid Res. 49: 2101-2112.
12. Foo, R. S., K. Mani, and R. N. Kitsis. 2005. Death begets failure in the heart. J. Clin. Invest. 115: 565-571.
13. Boudina, S., and E. D. Abel. 2007. Diabetic cardiomyopathy revisited. Circulation. 115: 3213-3223.
14. Dyntar, D., M. Eppenberger-Eberhardt, K. Maedler, M. Pruschy, H. M. Eppenberger, G. A. Spinas, and M. Y. Donath. 2001. Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes. Diabetes. 50: 2105-2113.
15. Bielawska, A. E., J. P. Shapiro, L. Jiang, H. S. Melkonyan, C. Piot, C. L. Wolfe, L. D. Tomei, Y. A. Hannun, and S. R. Umansky. 1997. Ceramide is involved in triggering of cardiomyocyte apoptosis induced by ischemia and reperfusion. Am. J. Pathol. 151: 1257-1263.
16. Krown, K. A., M. T. Page, C. Nguyen, D. Zechner, V. Gutierrez, K. L. Comstock, C. C. Glembotski, P. J. Quintana, and R. A. Sabbadini. 1996. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest. 98: 2854-2865.
17. Morales, A., H. Lee, F. M. Goni, R. Kolesnick, and J. C. Fernandez-Checa. 2007. Sphingolipids and cell death. Apoptosis. 12: 923-939.
18. Duke, R. C., and K. S. Sellins. 1989. Target cell nuclear damage in addition to DNA fragmentation during cytotoxic T lymphocyte-mediated cytolysis. In Cellular Basis of Immune Modulation. J. G. Kaplan, D. R. Green, and R. C. Bleackley, editors. Alan R. Liss Inc., New York. 311-314.
19. Baranowski, M., P. Zabielski, A. Blachnio, and J. Gorski. 2008. Effect of exercise duration on ceramide metabolism in the rat heart. Acta Physiol. (Oxf.). 192: 519-529.
20. Sugita, M., M. Iwamori, J. Evans, R. H. McCluer, J. T. Dulaney, and H. W. Moser. 1974. High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber's disease. J. Lipid Res. 15: 223-226.
21. Li, C. M., S. B. Hong, G. Kopal, X. He, T. Linke, W. S. Hou, J. Koch, S. Gatt, K. Sandhoff, and E. H. Schuchman. 1998. Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase. Genomics. 50: 267-274.
22. Li, C. M., J. H. Park, X. He, B. Levy, F. Chen, K. Arai, D. A. Adler, C. M. Disteche, J. Koch, K. Sandhoff, et al. 1999. The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics. 62: 223-231.
23. Liu, H., M. Sugiura, V. E. Nava, L. C. Edsall, K. Kono, S. Poulton, S. Milstien, T. Kohama, and S. Spiegel. 2000. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 275: 19513-19520.
24. Noureddine, L., R. Azzam, G. Nemer, J. Bielawski, M. Nasser, F. Bitar, and G. S. Dbaibo. 2008. Modulation of total ceramide and constituent ceramide species in the acutely and chronically hypoxic mouse heart at different ages. Prostaglandins Other Lipid Mediat. 86: 49-55.
25. Hickson-Bick, D. L., M. L. Buja, and J. B. McMillin. 2000. Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes. J. Mol. Cell. Cardiol. 32: 511-519.
26. Summers, S. A. 2005. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45: 42-72.
27. Wilson, K. D., Z. Li, R. Wagner, P. Yue, P. Tsao, G. Nestorova, M. Huang, D. L. Hirschberg, P. G. Yock, T. Quertermous, et al. 2008. Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality. PLoS One. 3: e2609.
28. Chowdhry, M. F., H. A. Vohra, and M. Galinanes. 2007. Diabetes increases apoptosis and necrosis in both ischemic and nonischemic human myocardium: role of caspases and poly-adenosine diphosphate-ribose polymerase. J. Thorac. Cardiovasc. Surg. 134: 124-131.
29. Frustaci, A., J. Kajstura, C. Chimenti, I. Jakoniuk, A. Leri, A. Maseri, B. Nadal-Ginard, and P. Anversa. 2000. Myocardial cell death in human diabetes. Circ. Res. 87: 1123-1132.
30. Barouch, L. A., D. Gao, L. Chen, K. L. Miller, W. Xu, A. C. Phan, M. M. Kittleson, K. M. Minhas, D. E. Berkowitz, C. Wei, et al. 2006. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ. Res. 98: 119-124.
31. Wencker, D., M. Chandra, K. Nguyen, W. Miao, S. Garantziotis, S. M. Factor, J. Shirani, R. C. Armstrong, and R. N. Kitsis. 2003. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 111: 1497-1504.
32. Listenberger, L. L., D. S. Ory, and J. E. Schaffer. 2001. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 276: 14890-14895.
33. Kong, J. Y., and S. W. Rabkin. 2002. Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin. Am. J. Physiol. Heart Circ. Physiol. 282: H717-H725.
34. Fulop, N., R. B. Marchase, and J. C. Chatham. 2007. Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. Cardiovasc. Res. 73: 288-297.
35. Alemany, R., C. J. van Koppen, K. Danneberg, M. Ter Braak, and D. Meyer Zu Heringdorf. 2007. Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch. Pharmacol. 374: 413-428.